170 related articles for article (PubMed ID: 19735165)
1. Predictors of asthma control in everyday clinical practice in Switzerland.
Taegtmeyer AB; Steurer-Stey C; Price DB; Wildhaber JH; Spertini F; Leuppi JD
Curr Med Res Opin; 2009 Oct; 25(10):2549-55. PubMed ID: 19735165
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected].
Bousquet J; Gaugris S; Kocevar VS; Zhang Q; Yin DD; Polos PG; Bjermer L
Clin Exp Allergy; 2005 Jun; 35(6):723-7. PubMed ID: 15969661
[TBL] [Abstract][Full Text] [Related]
3. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
Allen-Ramey FC; Anstatt DT; Sajjan SG; Markson LE
Pharmacotherapy; 2005 Dec; 25(12):1752-60. PubMed ID: 16305295
[TBL] [Abstract][Full Text] [Related]
4. Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
O'Connor RD; Gilmore AS; Manjunath R; Stanford RH; Legorreta AP; Jhingran PM
Curr Med Res Opin; 2006 Mar; 22(3):453-61. PubMed ID: 16574029
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.
Raissy HH; Harkins M; Kelly F; Kelly HW
Pharmacotherapy; 2008 Mar; 28(3):287-94. PubMed ID: 18294107
[TBL] [Abstract][Full Text] [Related]
6. Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy.
Sazonov-Kocevar V; Laforest L; Travier N; Yin DD; Van Ganse E
Pediatr Allergy Immunol; 2006 Dec; 17(8):620-8. PubMed ID: 17121591
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy.
Johnston NW; Mandhane PJ; Dai J; Duncan JM; Greene JM; Lambert K; Sears MR
Pediatrics; 2007 Sep; 120(3):e702-12. PubMed ID: 17766511
[TBL] [Abstract][Full Text] [Related]
8. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
Lu S; Liu N; Dass SB; Reiss TF
J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
[TBL] [Abstract][Full Text] [Related]
9. Adherence to montelukast versus inhaled corticosteroids in children with asthma.
Carter ER; Ananthakrishnan M
Pediatr Pulmonol; 2003 Oct; 36(4):301-4. PubMed ID: 12950042
[TBL] [Abstract][Full Text] [Related]
10. [Clinical benefits of montelukast sodium treatment in chronic adult asthma].
Trofor A; Rascarachi G; Popa E; Chiseliţă I
Rev Med Chir Soc Med Nat Iasi; 2002; 107(2):298-302. PubMed ID: 12638278
[TBL] [Abstract][Full Text] [Related]
11. Asthma control in Switzerland: a general practitioner based survey.
Leuppi JD; Steurer-Stey C; Peter M; Chhajed PN; Wildhaber JH; Spertini F
Curr Med Res Opin; 2006 Nov; 22(11):2159-66. PubMed ID: 17076976
[TBL] [Abstract][Full Text] [Related]
12. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
13. ALOX5 promoter genotype and response to montelukast in moderate persistent asthma.
Telleria JJ; Blanco-Quiros A; Varillas D; Armentia A; Fernandez-Carvajal I; Jesus Alonso M; Diez I
Respir Med; 2008 Jun; 102(6):857-61. PubMed ID: 18339529
[TBL] [Abstract][Full Text] [Related]
14. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
[TBL] [Abstract][Full Text] [Related]
15. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Kopriva F; Dzubak P; Potesil J; Hajduch M
J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
[TBL] [Abstract][Full Text] [Related]
16. Montelukast in guidelines and beyond.
Bousquet J; Demoly P; Humbert M
Adv Ther; 2009 Jun; 26(6):575-87. PubMed ID: 19562275
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma.
Kawai S; Baba K; Matsubara A; Shiono H; Okada T; Yamaguchi E
J Asthma; 2008 Apr; 45(3):243-50. PubMed ID: 18415834
[TBL] [Abstract][Full Text] [Related]
18. Real-life effectiveness of Singulair (montelukast) in 506 children with mild to moderate asthma.
Amirav I
Isr Med Assoc J; 2008 Apr; 10(4):287-91. PubMed ID: 18548983
[TBL] [Abstract][Full Text] [Related]
19. Effects of exercise training and montelukast in children with mild asthma.
Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
[TBL] [Abstract][Full Text] [Related]
20. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
